435 related articles for article (PubMed ID: 11687548)
1. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
Gendron RL; Good WV; Adams LC; Paradis H
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548
[TBL] [Abstract][Full Text] [Related]
2. Conditional knockdown of tubedown-1 in endothelial cells leads to neovascular retinopathy.
Wall DS; Gendron RL; Good WV; Miskiewicz E; Woodland M; Leblanc K; Paradis H
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3704-12. PubMed ID: 15452080
[TBL] [Abstract][Full Text] [Related]
3. Tubedown-1 (Tbdn-1) suppression in oxygen-induced retinopathy and in retinopathy of prematurity.
Gendron RL; Good WV; Miskiewicz E; Tucker S; Phelps DL; Paradis H
Mol Vis; 2006 Feb; 12():108-16. PubMed ID: 16518308
[TBL] [Abstract][Full Text] [Related]
4. Tubedown-1 in remodeling of the developing vitreal vasculature in vivo and regulation of capillary outgrowth in vitro.
Paradis H; Liu CY; Saika S; Azhar M; Doetschman T; Good WV; Nayak R; Laver N; Kao CW; Kao WW; Gendron RL
Dev Biol; 2002 Sep; 249(1):140-55. PubMed ID: 12217325
[TBL] [Abstract][Full Text] [Related]
5. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
6. Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture.
Castellon R; Caballero S; Hamdi HK; Atilano SR; Aoki AM; Tarnuzzer RW; Kenney MC; Grant MB; Ljubimov AV
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2758-66. PubMed ID: 12147613
[TBL] [Abstract][Full Text] [Related]
7. Tubedown-1, a novel acetyltransferase associated with blood vessel development.
Gendron RL; Adams LC; Paradis H
Dev Dyn; 2000 Jun; 218(2):300-15. PubMed ID: 10842358
[TBL] [Abstract][Full Text] [Related]
8. Remodeling retinal neovascularization by ALK1 gene transfection in vitro.
Li B; Yin W; Hong X; Shi Y; Wang HS; Lin SF; Tang SB
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4553-60. PubMed ID: 18829861
[TBL] [Abstract][Full Text] [Related]
9. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
10. The 67-kd laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy.
Stitt AW; McKenna D; Simpson DA; Gardiner TA; Harriott P; Archer DB; Nelson J
Am J Pathol; 1998 May; 152(5):1359-65. PubMed ID: 9588904
[TBL] [Abstract][Full Text] [Related]
11. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey.
Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607
[TBL] [Abstract][Full Text] [Related]
12. Loss of tubedown expression as a contributing factor in the development of age-related retinopathy.
Gendron RL; Laver NV; Good WV; Grossniklaus HE; Miskiewicz E; Whelan MA; Walker J; Paradis H
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5267-77. PubMed ID: 20463314
[TBL] [Abstract][Full Text] [Related]
13. Tubedown associates with cortactin and controls permeability of retinal endothelial cells to albumin.
Paradis H; Islam T; Tucker S; Tao L; Koubi S; Gendron RL
J Cell Sci; 2008 Jun; 121(Pt 12):1965-72. PubMed ID: 18495841
[TBL] [Abstract][Full Text] [Related]
14. Cysteine-rich 61, a member of the CCN family, as a factor involved in the pathogenesis of proliferative diabetic retinopathy.
You JJ; Yang CH; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3447-55. PubMed ID: 19264885
[TBL] [Abstract][Full Text] [Related]
15. Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes.
Das A; McGuire PG; Eriqat C; Ober RR; DeJuan E; Williams GA; McLamore A; Biswas J; Johnson DW
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):809-13. PubMed ID: 10067990
[TBL] [Abstract][Full Text] [Related]
16. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization.
van Eeden PE; Tee LB; Lukehurst S; Lai CM; Rakoczy EP; Beazley LD; Dunlop SA
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4638-45. PubMed ID: 17003462
[TBL] [Abstract][Full Text] [Related]
17. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalization of integrins in proliferative retinal membranes.
Robbins SG; Brem RB; Wilson DJ; O'Rourke LM; Robertson JE; Westra I; Planck SR; Rosenbaum JT
Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3475-85. PubMed ID: 8056523
[TBL] [Abstract][Full Text] [Related]
19. Calcitriol is a potent inhibitor of retinal neovascularization.
Albert DM; Scheef EA; Wang S; Mehraein F; Darjatmoko SR; Sorenson CM; Sheibani N
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2327-34. PubMed ID: 17460298
[TBL] [Abstract][Full Text] [Related]
20. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin.
Zamora DO; Riviere M; Choi D; Pan Y; Planck SR; Rosenbaum JT; David LL; Smith JR
Mol Vis; 2007 Oct; 13():2058-65. PubMed ID: 18079679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
